Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence

Sepede, Gianna, Di lorio, Giuseppe, Lupi, Matteo, Sarchione, Fabiola, Acciavatti, Tiziano, Fiori, Federica, Santacroce, Rita, Martinotti, Giovanni, Gambi, Francesco, Di Giannantonio, Massimo · 2014 · Clinical Neuropharmacology

Abstract

OBJECTIVES: The treatment of bipolar disorder type I (BD-I) with a comorbid cocaine dependence disorder (CDD) is a challenge in current psychiatric practice. Drugs with proven efficacy in manic/mixed episodes, such as atypical antipsychotics and mood stabilizers, sometimes do not prevent depressive relapses; on the other hand, the use of antidepressants during acute depressive episodes may increase the risk of a manic switch. The aim of the present study was to investigate the short-term efficacy of bupropion augmentation in acutely depressed BD-I patients with co-occurring CDD. METHODS: Twelve depressed BD-I patients, with a comorbid CDD, treated with valproate 1000 to 1500 mg/d and aripiprazole 10 mg/d, were randomly assigned to receive bupropion 150 mg/d as an open-label add-on therapy (n = 5) or to continue their previous treatment (n = 7). RESULTS: After 4 weeks of observation, patients receiving add-on therapy with bupropion have improved in terms of Hamilton Depression Rating Scale scores and Drug Abuse Screening Test scores, with respect to those of the comparison group, whereas no significant increase of Young Mania Rating Scale scores over time was observed. CONCLUSIONS: Our preliminary findings suggest that combining bupropion with mood stabilizers and atypical antipsychotics may be a good therapeutic option in short-term treatment of depressed BD-I patients with comorbid CDD.

Overview

Integrity signals

Registry

Crossref · 10.1097/wnf.0000000000000011

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 16

Metadata

Authors
Sepede, G., Di lorio, G., Lupi, M., Sarchione, F., Acciavatti, T., Fiori, F., Santacroce, R., Martinotti, G., Gambi, F., & Di Giannantonio, M.
Affiliations
University of Chieti-Pescara (IT)
Corresponding author
  • Sepede, Gianna
  • Lupi, Matteo
  • Sarchione, Fabiola
  • Acciavatti, Tiziano
  • Fiori, Federica
  • Santacroce, Rita
  • Martinotti, Giovanni
  • Gambi, Francesco
Venue
Clinical Neuropharmacology
Published
2014-01
Volume
37
Issue
1
Pages
17-21
ISSN
0362-5664 (ISSN-L)
OpenAlex
W2144025991
Cited by
16
References
39
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 1
FWCI
1.53
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
Keywords
bupropion, bipolar I disorder, cocaine dependence, comorbidities, adjunctive therapy, antidepressant augmentation, depressive episodes, manic switch, valproic acid, aripiprazole, mood stabilizers, atypical antipsychotics
MeSH terms
Aripiprazole, Adolescent, Adult, Analysis of Variance, Bipolar Disorder, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Piperazines, Psychiatric Status Rating Scales, Antipsychotic Agents, Valproic Acid, Quinolones, Bupropion, Antidepressive Agents, Second-Generation, Cocaine-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. https://app.cochat.ai/papers/10.1097/wnf.0000000000000011
The paper
Sepede, G., Di lorio, G., Lupi, M., Sarchione, F., Acciavatti, T., Fiori, F., Santacroce, R., Martinotti, G., Gambi, F., & Di Giannantonio, M. (2014). Bupropion as an add‐on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.